Back to search

Germany· DE-A57-11c1a49acd7b7cec

Treprostinil Beta

A treprostinil product containing treprostinil, registered in Germany by Betapharm Arzneimittel Gmbh. The same ATC class is registered in 17 of our 19 countries.

ATC B01AC21

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedTreprostinil BetaATCB01AC21REGISTER NO.DE-A57-11c1a49acd7b7c…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Treprostinil is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AC21 (treprostinil), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 9 of them publish a price we can compare per daily dose

Treprostinil · ATC B01AC21

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Treprostinil
Manufacturer
Betapharm Arzneimittel Gmbh
Country
Germany (DE)
ATC code
B01AC21
ATC class
Treprostinil
Defined daily dose
4.3 mg, P
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

371 interactions on record for treprostinil.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Treprostinil · interactions on record

371 records

  • 34 severe
  • 295 moderate
  • 2 minor
  • 40 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Treprostinil in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All treprostinil products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Remodulin, Treposa
  • Belgium · Remodulin, Tresuvi
  • Bulgaria · Тресуви
  • Cyprus · Remodulin
  • Czechia · Remodulin, Treprostinil Tillomed
  • Denmark · Remodulin, Treprostinil Tillomed
  • Estonia · Remodulin, Tresuvi
  • Spain · Treprostinilo Dr. Reddys, Treprostinilo Ferrer
  • Finland · Remodulin, Treposa
  • France · Remodulin, Treposuvi
  • United Kingdom (Northern Ireland) · Treprostinil Dr. Reddy's Laboratories (Uk), Treprostinil Tillomed
  • Greece · Remodulin, Treprostinil Tillomed
  • Croatia · Remodulin, Treprostinil Tillomed
  • Hungary · Remodulin, Treprostinil Zentiva
  • Ireland · Treposuvi, Treprostinil Tillomed
  • Iceland · Remodulin, Trepulmix
  • Italy · Remodulin, Treprostinil Dr. Reddy’s
  • Liechtenstein · Trepulmix
  • Lithuania · Remodulin, Treprostinil Tillomed
  • Luxembourg · Remodulin
  • Latvia · Remodulin, Treposuvi
  • Malta · Tresuvi
  • Netherlands · Remodulin, Treposuvi
  • Norway · Remodulin, Treprostinil Tillomed
  • Poland · Remodulin, Treprostinil Reddy
  • Portugal · Remodulin, Treprostinilo Tillomed
  • Romania · Tresuvi
  • Sweden · Remodulin, Treprostinil Tillomed
  • Slovenia · Remodulin, Treprostinil Amomed
  • Slovakia · Remodulin, Treprostinil Tillomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5a47e6f-942e-4d84-ada2-a9031645e610
GET /v1/drugs/f5a47e6f-942e-4d84-ada2-a9031645e610?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use ,Subcutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Treprostinil",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about treprostinil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.